Next Article in Journal
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
Next Article in Special Issue
Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
Previous Article in Journal
Induction of WNT16 via Peptide-mRNA Nanoparticle-Based Delivery Maintains Cartilage Homeostasis
Previous Article in Special Issue
Hyaluronate Nanoparticles as a Delivery System to Carry Neuroglobin to the Brain after Stroke
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(1), 72; https://doi.org/10.3390/pharmaceutics12010072
Action Date Notes Link
article xml file uploaded 17 January 2020 09:25 CET Original file -
article xml uploaded. 17 January 2020 09:25 CET Update https://www.mdpi.com/1999-4923/12/1/72/xml
article pdf uploaded. 17 January 2020 09:25 CET Version of Record https://www.mdpi.com/1999-4923/12/1/72/pdf
article supplementary file uploaded. 17 January 2020 09:25 CET - https://www.mdpi.com/1999-4923/12/1/72#supplementary
article html file updated 17 January 2020 09:26 CET Original file -
article html file updated 5 February 2020 12:40 CET Update -
article html file updated 15 February 2020 03:45 CET Update -
article html file updated 20 July 2022 17:46 CEST Update https://www.mdpi.com/1999-4923/12/1/72/html
Back to TopTop